• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Halobenzoic acids and derivatives

Recent Advances in the Application of 2-Chloro-6-(5-formylthiophen-3-yl)benzoic acid (CAS: 1261904-23-7) in Chemical Biology and Pharmaceutical Research

2-Chloro-6-(5-formylthiophen-3-yl)benzoic acid (CAS: 1261904-23-7) has emerged as a promising scaffold in chemical biology and pharmaceutical research due to its unique structural features and versatile reactivity. This compound, characterized by a benzoic acid core substituted with a chloro group and a formylthiophene moiety, has garnered significant attention for its potential applications in drug discovery, particularly in the development of small-molecule inhibitors and probes for biological targets. Recent studies have explored its utility in medicinal chemistry, highlighting its role as a key intermediate in the synthesis of bioactive molecules.

One of the most notable applications of 2-Chloro-6-(5-formylthiophen-3-yl)benzoic acid is its use in the design of kinase inhibitors. Kinases are critical regulators of cellular signaling pathways, and their dysregulation is implicated in various diseases, including cancer and inflammatory disorders. Researchers have leveraged the reactive aldehyde group of this compound to introduce diverse pharmacophores, enabling the development of selective kinase inhibitors with improved potency and pharmacokinetic properties. For instance, a recent study demonstrated its incorporation into a novel series of EGFR inhibitors, showing promising activity against resistant mutants.

In addition to its role in kinase inhibition, this compound has been employed in the synthesis of covalent inhibitors targeting cysteine residues in proteins. The chloro and formyl groups provide orthogonal reactivity, allowing for the precise modification of protein targets. A 2023 study published in the Journal of Medicinal Chemistry reported the use of 2-Chloro-6-(5-formylthiophen-3-yl)benzoic acid as a building block for covalent inhibitors of SARS-CoV-2 main protease, showcasing its potential in antiviral drug development. The study highlighted the compound's ability to form stable adducts with the protease's active site, thereby inhibiting viral replication.

Beyond its applications in drug discovery, 2-Chloro-6-(5-formylthiophen-3-yl)benzoic acid has also been explored as a fluorescent probe for imaging applications. The thiophene moiety confers favorable photophysical properties, making it suitable for the detection of biomolecules in live cells. A recent publication in Chemical Communications detailed its use in the development of a turn-on fluorescent probe for detecting reactive oxygen species (ROS) in cancer cells, providing insights into oxidative stress dynamics. This application underscores the compound's versatility in chemical biology.

Despite its promising attributes, challenges remain in the optimization of 2-Chloro-6-(5-formylthiophen-3-yl)benzoic acid derivatives for clinical use. Issues such as solubility, metabolic stability, and off-target effects need to be addressed through systematic structure-activity relationship (SAR) studies. Recent advancements in computational chemistry and high-throughput screening have facilitated the rational design of derivatives with improved properties, as evidenced by a 2023 study in ACS Medicinal Chemistry Letters. The study employed molecular docking and dynamics simulations to predict the binding modes of derivatives, guiding the synthesis of compounds with enhanced selectivity.

In conclusion, 2-Chloro-6-(5-formylthiophen-3-yl)benzoic acid (CAS: 1261904-23-7) represents a valuable tool in chemical biology and pharmaceutical research. Its multifunctional scaffold enables diverse applications, from kinase inhibition to fluorescent probing, and ongoing research continues to uncover new opportunities for its use. As the field advances, further exploration of its derivatives and mechanisms of action will likely yield innovative therapeutic and diagnostic agents, solidifying its role in the future of drug discovery.

• 1261914-07-1(2-Chloro-6-(thiophen-2-yl)benzoic acid)
• 1261890-51-0(2-(2-Formylthiophen-4-YL)-5-methylbenzoic acid)
• 1261909-35-6(2-chloro-5-(5-formylthiophen-2-yl)benzoic acid)
• 62497-25-0(2,5-Thiophenedicarboxylic acid, 3,4-bis(2-chlorophenyl)-)
• 1261928-30-6(4-Chloro-3-(5-formylthiophen-3-yl)benzoic acid)
• 1261905-69-4(2-(2-Formylthiophen-4-YL)-6-methylbenzoic acid)
• 1261914-14-0(2-Chloro-4-(thiophen-3-YL)benzoic acid)
• 62497-26-1(2,5-Thiophenedicarboxylic acid, 3,4-bis(3-chlorophenyl)-)
• 1261908-93-3(2-Chloro-6-(thiophen-3-yl)benzoic acid)
• 1261928-20-4(4-Chloro-2-(5-formylthiophen-3-yl)benzoic acid)